| __timestamp | Corcept Therapeutics Incorporated | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 72429000 |
| Thursday, January 1, 2015 | 36949000 | 78634000 |
| Friday, January 1, 2016 | 45240000 | 75374000 |
| Sunday, January 1, 2017 | 62416000 | 92157000 |
| Monday, January 1, 2018 | 81289000 | 93326000 |
| Tuesday, January 1, 2019 | 100359000 | 103132000 |
| Wednesday, January 1, 2020 | 105326000 | 110171000 |
| Friday, January 1, 2021 | 122356000 | 218817000 |
| Saturday, January 1, 2022 | 152848000 | 233827000 |
| Sunday, January 1, 2023 | 184259000 | 267194000 |
Unlocking the unknown
In the competitive landscape of the healthcare sector, effective cost management is crucial. Over the past decade, Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated have demonstrated distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Lantheus Holdings saw a remarkable 270% increase in SG&A expenses, peaking at $267 million in 2023. This growth reflects their strategic investments in expanding operations and market reach. Meanwhile, Corcept Therapeutics experienced a 428% rise, reaching $184 million in the same year, indicating their aggressive push in research and development. These trends highlight the dynamic nature of financial strategies in the healthcare industry, where balancing operational costs with innovation is key. As these companies continue to evolve, their SG&A expenses offer valuable insights into their strategic priorities and market positioning.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated Trends and Insights
Alnylam Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Genmab A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Insmed Incorporated and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Operational Costs Compared: SG&A Analysis of Lantheus Holdings, Inc. and HUTCHMED (China) Limited
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
Corcept Therapeutics Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc. Trends and Insights